PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
15-Dec-2020 Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030 Sanofi
15-Dec-2020 New Clinical Research Accreditation Launches to Meet Industry Demands GCSA
15-Dec-2020 Worldwide Trends in Plasma Therapy Market FnF Research
14-Dec-2020 Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Ergomed plc
14-Dec-2020 OncoZenge raises MSEK 10 ahead of spin-off and separate listing Moberg Pharma
14-Dec-2020 HBC and Tenet Partners initiate a long-term collaboration to build a global brand and launch HBC’s own branded consumer health products Hofseth BioCare ASA
14-Dec-2020 Grant awarded to Qlucore to aid clinical diagnostics of cancer Qlucore
14-Dec-2020 European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment Novartis
14-Dec-2020 Freeline Reports Updated Data from Phase 1/2 B-AMAZE Trial in Hemophilia B Freeline
14-Dec-2020 Pepscope Secures Investment to Radically Improve Development and Application of Kinase Inhibitor Therapies Pepscope
14-Dec-2020 Calibre Scientific Enters the Canadian Market and Expands Product Portfolio With the Acquisition of Canadian Life Science Calibre Scientific
10-Dec-2020 Boehringer Ingelheim to Acquire NBE-Therapeutics for EUR 1.18 Billion, Significantly Enhancing Its Cancer Pipeline Portfolio with Novel Antibody-Drug Conjugates Boehringer Ingelheim
10-Dec-2020 Research reveals portable digital chest drainage systems could help minimise spread of COVID-19 Medela
10-Dec-2020 Nokia and Vi Business partner to enable digital transformation for enterprises Nokia
10-Dec-2020 ALUNBRIG▼(brigatinib) now available on the NHS in England, Wales and Northern Ireland for adults with ALK-positive advanced non-small cell lung cancer who have not been previously treated with an ALK inhibitor Takeda UK Ltd
10-Dec-2020 Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod to Treat Suspected Organ Dysfunction or Failure in Patients with Necrotizing Soft Tissue Infection (“Flesh-Eating Disease”) Atox Bio
10-Dec-2020 Nokia AVA helps CSPs reduce energy bills by up to 20% Nokia
10-Dec-2020 Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents Moderna
10-Dec-2020 Arctoris appoints three experienced industry executives as members of its Advisory Board Arctoris
10-Dec-2020 CPL UK Healthcare (RIG) win back to back framework awards across the NHS. CPL UK Healthcare